| Visit | Category | Celecoxib 200 mg bid n (%) |
Diclofenac SR 75 mg bid Plus Omeprazole 20 mg qd n (%) |
|---|---|---|---|
| Screening | Good/Very good | 280 (12.7) | 285 (12.9) |
| Fair | 1315 (59.7) | 1328 (60.1) | |
| Poor/Very poor | 608 (27.6) | 598 (27.0) | |
| Baseline | Good/Very good | 237 (10.7) | 226 (10.2) |
| Fair | 1286 (58.3) | 1311 (59.2) | |
| Poor/Very poor | 684 (31.0) | 676 (30.5) | |
| Month 1 | Good/Very good | 877 (42.7) | 940 (46.1) |
| Fair | 985 (47.9) | 939 (46.1) | |
| Poor/Very poor | 194 (9.4) | 160 (7.8) | |
| Month 2 | Good/Very good | 1021 (52.0) | 999 (53.3) |
| Fair | 815 (41.5) | 756 (40.3) | |
| Poor/Very poor | 129 (6.6) | 121 (6.4) | |
| Month 4 | Good/Very good | 1037 (56.9) | 1001 (58.1) |
| Fair | 683 (37.5) | 630 (36.6) | |
| Poor/Very poor | 101 (5.5) | 92 (5.3) | |
| Month 6 | Good/Very good | 1214 (57.0) | 1204 (57.6) |
| Fair | 737 (34.6) | 723 (34.6) | |
| Poor/Very poor | 179 (8.4) | 163 (7.8) | |
| Final (LOCF) | Good/Very good | 1250 (56.6) | 1246 (56.3) |
| Fair | 770 (34.9) | 789 (35.7) | |
| Poor/Very poor | 187 (8.5) | 178 (8.0) |